RUBY Market Cap History



Below is a table of the RUBY market cap history going back to 7/31/2018:

Date RUBY Market Cap
7/31/20181.66B
10/31/20181.30B
2/28/20191.26B
4/30/20191.40B
7/31/20191.06B
10/31/2019705.44M
3/2/2020628.12M
4/30/2020486.88M
7/31/2020396.57M
10/30/2020342.31M
1/29/2021971.75M
4/30/20212.23B
7/30/20211.93B
10/29/20211.28B
1/31/2022608.04M
4/29/2022149.75M
7/29/202263.43M
10/31/202230.64M
1/31/202323.59M

Also see: RUBY Shares Outstanding History
and RUBY YTD Return
RUBY Historical Market Cap:
-61.09% CAGR
RUBY Historical Market Cap: +-61.09% CAGR

Mouse over chart for data details
7/31/2018 ...1/31/2023
Rubius Therapeutics is a clinical-stage biopharmaceutical company that is biologically engineering red blood cells to develop a class of cellular medicines called Red Cell Therapeutics for the treatment of cancer and autoimmune diseases. Co.'s platform, RED PLATFORM, biologically engineers and cultures allogeneic red blood cell therapies that enable multiple applications, or modalities. Co.'s immune stimulation for the treatment of cancer includes RTX-240, which is designed to stimulate the immune system by activating and expanding both NK and CD8+ memory T cells to generate an anti-tumor response; and RTX-224, which is designed as an immune agonist of both adaptive and innate responses. We show 19 historical shares outstanding datapoints in our RUBY shares outstanding history coverage, used to compute RUBY market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing RUBY market cap history over the course of time is important for investors interested in comparing RUBY's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of RUBY versus a peer is one thing; comparing RUBY market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like RUBY can fluctuate over the course of history. With this page we aim to empower investors researching RUBY by allowing them to research the RUBY market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree RUBY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Rubius Therapeutics (RUBY) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

RVMD Market Cap History
RVNC Market Cap History
RVPH Market Cap History
RVTY Market Cap History
RXDX Market Cap History
RXII Market Cap History
RXRX Market Cap History
RXST Market Cap History
RYTM Market Cap History
RYZB Market Cap History
More Healthcare companies »

 

RUBY Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.